PAVmed Inc reports results for the quarter ended September 30 - Earnings Summary

PAVmed

14/11/2024 21:01

* PAVmed Inc  PAVM.OQ  reported quarterly adjusted earnings
of
$1.44​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of $-2.40.  The mean expectation of three analysts for the
quarter was for earnings of $1.98 per share. Wall Street
expected results to range from $-1.04 to $4.99 per share.
    * Revenue rose 25.9% to $996.00 thousand from a year ago;
analysts
expected $1.09 million. 
    * PAVmed Inc's reported EPS for the quarter was $1.44​.
    * The company reported quarterly net income of $64.32
million.
    * PAVmed Inc shares had fallen by 17.1% this quarter and
lost 71.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 261.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for PAVmed Inc is
4.00 
This summary was machine generated from LSEG data November 14 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      1.98           1.44           Missed
 Jun. 30 2024      -1.45          -1.19          Beat
 Mar. 31 2024      -1.67          -2.62          Missed
 Dec. 31 2023      -1.89          -1.81          Beat